Recombinant Human Thymosin Beta 4 for Injection(NL005) for Acute Myocardial Infarction

NCT07586865 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

189

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myocardial Infarction (AMI)
Acute Myocardial Infarction of Anterior Wall
Acute Myocardial Infarction With ST Elevation
Acute Myocardial Infarction of Left Ventricle
Acute Myocardial Infarction With ST Segment Elevation

Interventions

DRUG: Recombinant Human Thymosin Beta 4 Injection (NL005)
DRUG: Placebo

Sponsor

Beijing Northland Biotech. Co., Ltd.